-
Evaluating Biomimetic Chromatography for Pulmonary Drug Perm
2026-07-16
This study systematically compares immobilised artificial membrane liquid chromatography (IAM LC) and liposome electrokinetic capillary chromatography (LEKC) for predicting drug partitioning and pulmonary permeability. The findings show that LEKC more accurately models lung membrane passage for certain drug classes, providing a nuanced framework for screening drug candidates targeting respiratory delivery.
-
Merimepodib (VX-497): IMPDH Inhibitor for Antiviral & Immuno
2026-07-15
Merimepodib (VX-497) is a selective, noncompetitive inhibitor of inosine monophosphate dehydrogenase (IMPDH) with oral bioavailability, enabling disruption of guanine nucleotide biosynthesis. This compound demonstrates potent antiviral, immunosuppressive, and antiproliferative activities in both in vitro and in vivo models. APExBIO provides Merimepodib (SKU B1112) for research applications in oncology, virology, and immunology.
-
Mechanistic Risks of Drug Interactions: Oteseconazole in Foc
2026-07-15
This article analyzes a comprehensive study of enzyme- and transporter-mediated drug-drug interactions (DDIs) among new molecular entities approved by the FDA in 2022, with a focus on Oteseconazole (VT-1161). The findings provide mechanistic insights into DDI risks, influencing both drug labeling and antifungal research strategies.
-
Mechanistic DDI Assessment of Oteseconazole in 2022 FDA Revi
2026-07-14
This article analyzes the detailed DDI risk assessment for Oteseconazole (VT-1161) presented in the 2022 FDA drug approvals review. The paper’s integration of in vitro, in silico, and clinical data provides a nuanced understanding of Oteseconazole’s interaction liabilities, particularly as a selective CYP51 inhibitor with minimal CYP3A4 involvement, informing safer antifungal therapy design.
-
CmOGD2-Mediated Ferroptosis Drives Citrus Canker Resistance
2026-07-14
This study elucidates the complex regulatory network through which Citron CmOGD2 confers resistance to citrus canker by promoting iron uptake and reactive oxygen species (ROS)-dependent ferroptosis. The findings reveal how host-pathogen interactions modulate iron and redox metabolism to influence plant immunity, offering new strategies for engineering disease resistance.
-
Neurotensin (CAS 39379-15-2): Reliable Tool for GPCR & miRNA
2026-07-13
This article provides scenario-driven guidance for biomedical researchers optimizing cell viability and signaling assays with Neurotensin (CAS 39379-15-2), also known as SKU B5226. Drawing on quantitative data and recent literature, it demonstrates how this APExBIO reagent delivers reproducible results in GPCR trafficking and miRNA regulation workflows.
-
AG-120 (Ivosidenib): Optimizing Mutant IDH1 AML Research Wor
2026-07-13
AG-120 (Ivosidenib) transforms mutant IDH1 acute myeloid leukemia (AML) research by enabling robust 2-hydroxyglutarate reduction and driving myeloid differentiation. This guide provides practical protocols, workflow enhancements, and troubleshooting strategies tailored for translational and bench scientists.
-
Hagenia abyssinica Extracts: Field Trials for Molluscicidal
2026-07-12
This study presents the first small-scale field trial data evaluating the molluscicidal activity of Hagenia abyssinica flower extracts against Biomphalaria snail species, primary schistosomiasis vectors. By assessing both efficacy and acute fish toxicity, the research addresses the ecological trade-offs of plant-derived vs. synthetic molluscicides, informing safer snail control strategies in endemic regions.
-
Deep Learning for Field Detection of Sweetpotato Virus Disea
2026-07-10
Ding et al. introduce a deep learning-based segmentation approach for rapid, accurate identification of sweetpotato virus disease (SPVD) in field imagery. By integrating a novel Attention Pyramid Fusion module and advanced data augmentation, their method significantly outperforms prior techniques and has direct implications for breeding and disease management.
-
NFIA Regulates Bone Homeostasis via Osteoclast and Osteoblas
2026-07-09
The referenced study uncovers nuclear factor I/A (NFIA) as a previously unrecognized, multifunctional regulator of bone homeostasis, acting in mesenchymal stem/progenitor cells to coordinate osteoclast and osteoblast differentiation. These findings have important implications for understanding age-related bone loss and highlight NFIA as a potential target in skeletal disease research.
-
Flumequine: Applied DNA Topoisomerase II Inhibitor Workflows
2026-07-09
Flumequine empowers DNA replication and drug response studies with precision, owing to its robust inhibition of topoisomerase II and reliable solubility in DMSO. Explore advanced setup strategies, in vitro protocol optimizations, and troubleshooting guidance that set Flumequine apart in cancer and antibiotic resistance research.
-
Resiniferatoxin (RTX): Strategic Translation for Pain & Immu
2026-07-08
This thought-leadership article explores the dual mechanistic and translational potential of Resiniferatoxin (RTX) as an ultra-potent TRPV1 agonist. Blending recent immunopharmacology evidence with actionable protocol guidance, it highlights RTX's unique capacity for targeted sensory neuron inactivation, addresses emerging immune considerations, and offers a strategic outlook for researchers navigating pain, inflammation, and cross-domain therapeutic frontiers.
-
Host CBS Regulates Inflammation in S. aureus-Induced Mastiti
2026-07-08
This study reveals that host-derived cystathionine-β-synthase (CBS) plays a crucial role in balancing inflammation and tissue integrity during Staphylococcus aureus-induced udder infection. The findings highlight CBS as a key modulator of mammary immune responses, offering potential new targets for managing mastitis and related infectious diseases.
-
Early Pheromone Exposure Drives Neurodegeneration in C. eleg
2026-07-07
Peng et al. (2023) uncover how early-life pheromone perception in C. elegans profoundly remodels neurodevelopment and accelerates adult neurodegeneration via glutamatergic and neuropeptide signaling pathways. Their findings provide mechanistic insight into how environmental chemical cues can modulate neural aging, with implications for understanding environmental contributions to neurodegenerative diseases.
-
JZL184: Selective Monoacylglycerol Lipase Inhibitor for Endo
2026-07-07
JZL184 is a potent, selective monoacylglycerol lipase inhibitor that elevates brain 2-arachidonoylglycerol (2-AG) levels to modulate endocannabinoid signaling. Its mechanism involves CB1 receptor-mediated pathways, supporting neuropharmacology and pain research with reliable, verifiable experimental benchmarks.